Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$7,415,670
+$559,373 QoQ
Shares Held
29,199
+4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,301
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pure Financial Advisors, LLC holds $38,114,911 across 13 Drug Manufacturers - General names. JNJ ranks #3 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,010 | $8,408,005 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,640 | $7,663,740 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
29,199 | $7,415,670 | |
| 4 | ABBV |
AbbVie Inc.
|
23,887 | $6,010,924 | |
| 5 | AMGN |
Amgen Inc
|
7,972 | $2,886,820 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,483 | $1,295,470 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,775 | $982,293 | |
| 8 | NVO |
Novo Nordisk A S
|
16,779 | $804,385 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,415,670 | 29,199 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $6,856,297 | 28,049 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $5,635,041 | 27,229 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $5,347,883 | 28,842 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $4,282,651 | 28,037 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,299,718 | 19,897 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,520,871 | 17,431 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,074,278 | 18,970 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,728,368 | 18,667 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,643,829 | 16,713 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,029,312 | 12,947 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $1,628,989 | 10,459 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,686,648 | 10,190 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,556,355 | 10,041 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $1,134,446 | 6,422 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,184,033 | 7,248 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $1,277,006 | 7,194 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,248,230 | 7,043 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,231,875 | 7,201 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,117,903 | 6,922 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,211,003 | 7,351 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $1,158,996 | 7,052 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $1,074,118 | 6,825 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $960,424 | 6,451 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $879,218 | 6,252 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $679,253 | 5,180 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||